Cargando…
Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults
BACKGROUND: Ventilator-associated pneumonia (VAP) is one of the most common intensive care unit (ICU)-acquired infections, which can cause multiple adverse events. Due to bacterial mutation and overuse of antimicrobial drugs, multidrug-resistant organisms (MDRO) has become one of the major causes of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636807/ https://www.ncbi.nlm.nih.gov/pubmed/36333679 http://dx.doi.org/10.1186/s12872-022-02890-5 |
_version_ | 1784825035492425728 |
---|---|
author | Wang, Meizhu Xu, Xi Wu, Shuo Sun, Huiying Chang, Yan Li, Meng Zhang, Xiaoxiao Lv, Xing Yang, Zhaoxu Ti, Xinyu |
author_facet | Wang, Meizhu Xu, Xi Wu, Shuo Sun, Huiying Chang, Yan Li, Meng Zhang, Xiaoxiao Lv, Xing Yang, Zhaoxu Ti, Xinyu |
author_sort | Wang, Meizhu |
collection | PubMed |
description | BACKGROUND: Ventilator-associated pneumonia (VAP) is one of the most common intensive care unit (ICU)-acquired infections, which can cause multiple adverse events. Due to bacterial mutation and overuse of antimicrobial drugs, multidrug-resistant organisms (MDRO) has become one of the major causes of postoperative VAP infections in cardiac patients. Therefore, this study aims to explore the risk factors for VAP with MDRO following cardiac surgery in adults. METHODS: The clinical data of adult VAP patients following cardiac surgery in the hospital from Jan 2017 to May 2021 were analyzed retrospectively, and the patients were divided into the MDRO VAP group and the non-MDRO VAP group. Univariable and multivariable logistic regression analyses were performed on risk factors in patients with MDRO VAP. The species and drug sensitivity of pathogens isolated from the VAP patients were also analyzed. RESULTS: A total of 61 VAP cases were involved in this study, with 34 cases in the MDRO VAP group (55.7%) and 27 cases in the non-MDRO VAP group (44.3%). Multivariable logistic regression analysis showed that independent risk factors for MDRO VAP included preoperative creatinine clearance rate (CCR) ≥ 86.6ml, intraoperative cardiopulmonary bypass (CPB) time ≥ 151 min, postoperative acute kidney injury (AKI) and nasal feeding. Gram-negative bacilli were the main pathogens in VAP patients (n = 54, 90.0%), with the highest rate of Acinetobacter baumannii (n = 24, 40.0%). Additionally, patients with MDRO VAP had a significantly longer postoperative intensive care unit (ICU) duration and higher hospitalization costs than non-MDRO VAP patients, but there was no notable difference in the 28-day mortality rate between the two groups. CONCLUSION: Based on implementing measures to prevent VAP, clinicians should pay more attention to patients with kidney disease, longer intraoperative CPB time, and postoperative nasal feeding to avoid MDRO infections. |
format | Online Article Text |
id | pubmed-9636807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96368072022-11-06 Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults Wang, Meizhu Xu, Xi Wu, Shuo Sun, Huiying Chang, Yan Li, Meng Zhang, Xiaoxiao Lv, Xing Yang, Zhaoxu Ti, Xinyu BMC Cardiovasc Disord Research BACKGROUND: Ventilator-associated pneumonia (VAP) is one of the most common intensive care unit (ICU)-acquired infections, which can cause multiple adverse events. Due to bacterial mutation and overuse of antimicrobial drugs, multidrug-resistant organisms (MDRO) has become one of the major causes of postoperative VAP infections in cardiac patients. Therefore, this study aims to explore the risk factors for VAP with MDRO following cardiac surgery in adults. METHODS: The clinical data of adult VAP patients following cardiac surgery in the hospital from Jan 2017 to May 2021 were analyzed retrospectively, and the patients were divided into the MDRO VAP group and the non-MDRO VAP group. Univariable and multivariable logistic regression analyses were performed on risk factors in patients with MDRO VAP. The species and drug sensitivity of pathogens isolated from the VAP patients were also analyzed. RESULTS: A total of 61 VAP cases were involved in this study, with 34 cases in the MDRO VAP group (55.7%) and 27 cases in the non-MDRO VAP group (44.3%). Multivariable logistic regression analysis showed that independent risk factors for MDRO VAP included preoperative creatinine clearance rate (CCR) ≥ 86.6ml, intraoperative cardiopulmonary bypass (CPB) time ≥ 151 min, postoperative acute kidney injury (AKI) and nasal feeding. Gram-negative bacilli were the main pathogens in VAP patients (n = 54, 90.0%), with the highest rate of Acinetobacter baumannii (n = 24, 40.0%). Additionally, patients with MDRO VAP had a significantly longer postoperative intensive care unit (ICU) duration and higher hospitalization costs than non-MDRO VAP patients, but there was no notable difference in the 28-day mortality rate between the two groups. CONCLUSION: Based on implementing measures to prevent VAP, clinicians should pay more attention to patients with kidney disease, longer intraoperative CPB time, and postoperative nasal feeding to avoid MDRO infections. BioMed Central 2022-11-04 /pmc/articles/PMC9636807/ /pubmed/36333679 http://dx.doi.org/10.1186/s12872-022-02890-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Meizhu Xu, Xi Wu, Shuo Sun, Huiying Chang, Yan Li, Meng Zhang, Xiaoxiao Lv, Xing Yang, Zhaoxu Ti, Xinyu Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title | Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title_full | Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title_fullStr | Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title_full_unstemmed | Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title_short | Risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
title_sort | risk factors for ventilator-associated pneumonia due to multi-drug resistant organisms after cardiac surgery in adults |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636807/ https://www.ncbi.nlm.nih.gov/pubmed/36333679 http://dx.doi.org/10.1186/s12872-022-02890-5 |
work_keys_str_mv | AT wangmeizhu riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT xuxi riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT wushuo riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT sunhuiying riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT changyan riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT limeng riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT zhangxiaoxiao riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT lvxing riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT yangzhaoxu riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults AT tixinyu riskfactorsforventilatorassociatedpneumoniaduetomultidrugresistantorganismsaftercardiacsurgeryinadults |